Feng Huayi, Cao Shouqing, Ouyang Qing, Li Huaikang, Li Xiubin, Chen Ke, Zhang Xiangyi, Huang Yan, Zhang Xu, Ma Xin
Medical School of Chinese PLA, Beijing, China.
Department of Urology, The Third Medical Center, Chinese PLA General Hospital, Beijing, China.
Transl Androl Urol. 2023 Feb 28;12(2):308-319. doi: 10.21037/tau-23-32. Epub 2023 Feb 20.
Germline pathogenic variants are estimated to affect 3-5% of patients with renal cell carcinoma (RCC). The identification of patients with hereditary RCC is important for cancer screening and treatment guidance.
Whole-exome sequencing (WES) (n=69) or gene panel sequencing containing 139 genes (n=54) related to germline cancer predisposition was used to analyze germline mutations in 123 patients with RCC admitted to Department of Urology, The Third Medical Center of Chinese PLA General Hospital. Chi-square test (χ) was used to analyze relationship between clinicopathologic parameters and germline mutations.
A total of 13 (10.57%) patients carried pathogenic or likely pathogenic germline mutations in 10 cancer predisposition genes, including , and . A total of 6 of these 10 cancer predisposition genes were associated with maintenance of genomic stability and DNA repair. Patients harboring pathogenic germline mutations tended to have an earlier RCC onset. The prevalence of deleterious mutations was higher in patients with bilateral or multifocal RCC compared to patients without bilateral or multifocal RCC. Patients with non-clear cell RCC (nccRCC) were significantly more likely to have RCC-associated gene mutations.
To our knowledge, this is the first report of pathogenic germline mutations in the and genes and heterozygous germline missense mutation in exon 5 of the gene c.563A>T:p.N188I in RCC. Young RCC patients, patients with bilateral or multifocal RCC, or patients with nccRCC are more likely to have pathogenic/potentially pathogenic germline mutations.
据估计,胚系致病变异影响3%至5%的肾细胞癌(RCC)患者。识别遗传性RCC患者对于癌症筛查和治疗指导至关重要。
采用全外显子组测序(WES)(n = 69)或包含139个与胚系癌症易感性相关基因的基因panel测序(n = 54),分析解放军总医院第三医学中心泌尿外科收治的123例RCC患者的胚系突变。采用卡方检验(χ)分析临床病理参数与胚系突变之间的关系。
共有13例(10.57%)患者在10个癌症易感基因中携带致病或可能致病的胚系突变,包括 、 和 。这10个癌症易感基因中共有6个与基因组稳定性维持和DNA修复相关。携带致病胚系突变的患者RCC发病往往较早。与无双侧或多灶性RCC的患者相比,双侧或多灶性RCC患者中有害突变的患病率更高。非透明细胞RCC(nccRCC)患者发生RCC相关基因突变的可能性显著更高。
据我们所知,这是RCC中 基因和 基因的致病胚系突变以及 基因第5外显子杂合胚系错义突变c.563A>T:p.N188I的首次报道。年轻的RCC患者、双侧或多灶性RCC患者或nccRCC患者更有可能携带致病/潜在致病的胚系突变。